Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.50
-0.27 (-0.80%)
Jul 20, 2026, 4:00 PM EDT - Market closed
HRMY Market Cap
HRMY has a market cap or net worth of $1.94 billion as of July 20, 2026. Its market cap has decreased by -4.05% in one year.
Market Cap
1.94B
Enterprise Value
1.46B
1-Year Change
-4.05%
Ranking
Category
Stock Price
$33.50
ChartMarket Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.94B, an increase of 320.66%. That is a compound annual growth rate of 27.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.94B | -10.02% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 2.02B |
| Viridian Therapeutics | 1.99B |
| AbCellera Biologics | 1.97B |
| GH Research | 1.97B |
| Ocular Therapeutix | 1.96B |
| Lakefront Biotherapeutics NV | 1.96B |
| UroGen Pharma | 1.96B |
| Damora Therapeutics | 1.94B |